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Bioavailability/T oxicity of Iron from 
Aerobically Processed Organic Fertilizer 
By: Stacey Wilson 
For an undergraduate Honor's project, I worked under the direction of Dr. 
Jeffery Hall to determine the bioavail~bility and toxicity of iron from Milorganite® 
fertilizer, an aerobically processed organic fertilizer. The Milorganite® Company 
is a subsidiary of the Milwaukee Municipal Sewage District and produces a 
fertilizer of high iron content (approximately 5-7%). The high iron content has 
resulted in concern about the toxic potential, which until now was unknown. This 
thesis paper will explain iron chemistry, bioavailability, requirements, absorption, 
toxicity, and treatments, followed by a description of fertilizer types and contents. 
This will be followed by a description and reasoning for the dosing study and the 
results from our clinical and histological observations, serum biochemistry, and 
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tissue mineral analysis. Finally, there will be a short summary and the 
conclusions we reached at the end of the study. 
Iron is a transition metal located in the fourth period, Group VIII elements 
of the standard periodic table and has the atomic number 26. Transition metals 
found in the center of the periodic table, such as iron, have many important and 
-
unique properties. A very significant property that iron demonstrates is the ability 
to exist in both a di-and tri-valence state. Iron can easily convert from the ferrous 
(2+) state to the ferric (3+) state and vice versa because of the electron 
configuration of the valence shell. Two electrons are found in the outermost shell 
of iron. The two electrons allow iron to participate in ionic bonding by achieving 
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an oxidation state of 2+. By donating both electrons to form a bond, iron can 
achieve a complete octet and hence, become very stable. However, iron can 
also achieve a seemingly unstable oxidation state of 3+ by donating three 
electrons. While the ability to donate electrons leading to such an unstable state 
(less than an octet) may seem impossible, the outcome can be explained by 
· .. ; 
observing iron's location in the periodic table. By donating three electrons, iron 
allows the d orbital to be only half full. Consequently, no electrons in the d orbital 
(which can contain a maximum of ten electrons) are paired, and a semi-stable 
configuration is obtained because all five remaining electrons spin in the same 
manner. The ferric state therefore allows for more versatility and stability. 
The unique bonding ability of iron explains the diversity of iron containing 
compounds. Not only do ferrous and ferric compounds differ in bonding, but 
many other properties differ as well. An important difference in the chemical 
properties of iron compounds is solubility. Ferrous iron compounds are generally 
more water-soluble than ferric compounds. The difference in solubility of the 
compounds gives iron a diverse range of bioavailability because certain iron 
compounds will be soluple (and thus available) and others will not. However, it is 
important to keep in mind that iron compounds have the ability to convert 
between the ferric and ferrous states, thereby altering solubility as well. 
Iron is a necessary element for mammals in many body functions. Heme 
groups (iron-containing porphyrin rings) in the hemoglobin of blood are 
responsible for the transport of oxygen throughout the body. In cellular 
respiration, the electron transport chain found in mitochondria is also composed 
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of heme groups that aid in the transfer of electrons. As electrons are passed 
between heme groups in the chain, energy is harvested and stored by forming 
ATP. Iron can also be found as a cofactor in an extensive list of enzymes 
necessary for a variety of body functions. For example, iron is essential for ATP 
production due to its central role in the electron transport chain. Peroxidase and 
. · . .: 
catalase are also enzymes that utilize iron. Cytochrome enzyme systems are 
also examples of iron-containing proteins. Iron in the body is not only necessary 
to transport oxygen and produce ATP, but also is necessary to prevent anemia, 
fatigue, anorexia, stunted growth, and low resistance to infection, once again 
demonstrating that iron is a vital component to living systems (McKinley Health 
Center, 2001 ). 
While iron is a necessary element, it is needed only in small quantities. 
Average iron consumption is 12-15 mg per day (Venugopal and Luckey, 1978). 
Once iron is consumed, concentrations within the body are regulated by 
absorption, not excretion. There are three mechanisms that regulate iron 
absorption. First, a dietary regulator acts such that increases in dietary iron are 
not continuously absorbed, due to the mucosal cells in the intestine having 
accumulated a manageable amount of iron and "blocking" additional uptake. 
Second, body stores regulate uptake so that as body iron stores fall, the mucosa! 
cells are signaled to both moderately increase absorption and increase transport 
of iron from the mucosa! cells into the blood. Finally, a eurythropoetic regulator 
by which, in response to anemia, the erythroid cells will signal the mucosa to 
increase iron absorption more significantly (Internet Pathology Lab, 2001 ). 
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Specific sites for iron absorption exist, however, competition by other 
elements for the active sites in the membrane can limit the amount of iron 
absorbed by the body. Iron can be more easily absorbed if a larger quantity is 
available. The bioavailability, nonetheless, depends on the form of the iron 
ingested. "The availability of Fe in a coordination complex rather than as an ion 
· .. ; 
determines its absorption from the digestive tract and transfer across the 
mucosal cells" (Venugopal and Luckey 1978). Once soluble ferrous iron is 
ingested, it is absorbed in a carrier-mediated fashion in the mucosal cells of the 
intestine and converted to the ferric state. 
Iron is stored by binding to the proteins ferritin or transferrin until the body 
indicates a need for iron in systemic circulation. The amount of ferritin in the 
blood is indicative of the amount of iron in the body because ferritin does not 
exist in the blood in large quantities. Once iron is needed, it is transported 
across the cell membrane via the transporter protein DMT 1 (the divalent metal 
transporter 1) into the plasma where it is bound to transferrin, the glycoprotein 
that allows iron to circulate in the bloodstream throughout the body. 
In an iron overdose, the mucosal cells seem to become overloaded with 
iron, even though there is an adequate amount of iron in the bloodstream. 
Absorption appears to become passive and concentration-dependent, rather than 
carrier-mediated possibly due to direct cellular damage of the mucosal cells. 
Ferritin increases in the bloodstream indicating that an overdose has occurred. 
In extreme overdoses, the binding capacity of transferrin can also be surpassed 
resulting in free iron circulating in the plasma. Free iron circulation leads to iron 
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poisoning because free iron is highly reactive and exhibits tissue-damaging 
effects throughout the body (Greentree and Hall, 1995). 
Free iron influences redox reactions with resultant lipid peroxidation and 
free radical formation (Massachusetts Poison Control System, 1997). Oxidation-
reduction reactions release hydrogen ions that create an acidic environment 
. ·-. .: 
within the blood and body thus disrupting the homeostatic pH of 7.4. Tissue 
effects are a direct result of both the peroxidative damage and the decrease in 
pH caused by the redox reactions. The effects of the redox reactions can 
primarily be observed in the gastrointestinal tract, liver, cardiovascular system, 
and brain because these organs have the greatest exposure to absorbed iron. 
Cells of these organs are damaged by free iron resulting in hepatic damage, 
myocardial failure, hemorrhagic necrosis in the lining of the stomach and small 
intestine, and seizures. The most significant effects can be observed in the 
cardiovascular system because excessive iron causes fatty necrosis of the 
myocardium, postarteriolar dilation, and increased capillary permeability. 
Consequently, reduced cardiac output, venous pooling, and diminished tissue 
perfusion occur (Greentree and Hall 1995). 
Clinical iron toxicosis is generally divided into four stages. The first stage 
of toxicosis is characterized by vomiting, diarrhea (usually bloody), and 
abdominal pain. This stage begins acutely and can last for up to six hours 
postingestion. The second stage can vary in length, lasting up to 24 hours, 
depending on the amount of iron ingested. The second stage is characterized by 
an apparent stabilization or improvement in the syndrome. The apparent 
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recovery, however, is quite misleading. The most devastating effects are those 
of stages three and four. Stage three is the most serious because it involves 
multiple system organ failure. Symptoms of stage three are lethargy, recurrence 
of gastrointestinal signs, metabolic acidosis, liver necrosis, cardiovascular 
collapse and shock. Death can also result if proper treatment is not given. The . • . ..; 
fourth and last stage of iron poisoning is observed weeks after the initial effects 
when ulcerations heal causing gastrointestinal scarring and subsequent lumenal 
obstruction (Greentree and Hall, 1995; Massachusetts Poison Control Systems, 
1997). 
Treatment of iron poisoning begins with stabilization of vital signs, followed 
by decontamination, chelation, and supportive care. Degree of intervention 
should be based upon a physical examination of the patient, calculation of the 
amount of iron ingested, and results of diagnostic testing and radiographs 
(Greentree and Hall 1995). In cases where a large amount of iron has been 
consumed, blood tests for determining serum iron, serum iron binding capacity, 
and serum chemistry are recommended. Hydrogen peroxide (3%) should be 
given as an emetic. If induced vomiting is unsuccessful, a gastric lavage under 
anesthesia will be necessary. Possible consideration of an emergency 
gastrostomy is suggested if a large amount of iron was ingested. Restoring 
proper fluid, electrolyte, and acid-base balances is essential and intravenous 
fluids are necessary. Chelation using Deferoxamine is recommended for only 
the most sever-e cases. Patients should be monitored for signs of gastrointestinal 
obstruction following recovery. Should scarring occur, corrective intervention and 
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support management are necessary (Greentree and Hall, 1995). 
Though toxic in large quantities, iron remains essential to life and can be 
consumed properly as part of a regular diet. There are two types of iron available 
for consumption. Heme iron is found only in meat, fish, and poultry and is 
absorbed easier than non-heme iron that is found primarily in fruits, vegetables, 
dried beans, nuts and grain products because heme iron has already been 
incorporated by the initial carrier into the necessary form for absorption (McKinley 
Health Center, 2001 ). Additional dietary iron is recommended for those people 
with an iron-deficient diet, pregnant women, and people who have experienced a 
high loss of blood. Dietary iron is available in vitamin supplements, which is the 
most common source of iron overdoses. Children and pets can accidentally 
consume a large quantity of dietary iron-containing vitamin supplements and 
experience acute iron toxicosis. There exists a possibility for iron to exist in 
bioavailable forms in processed organic fertilizer. Accidental ingestion of such a 
product could also lead to iron toxicosis, if the iron is highly bioavailable. 
By definition, a fertilizer is a plant nutrient. Nitrogen, Phosphorus, and 
Potassium (N, P, K, respectively) are three elements required by all forms of 
plant life. Nitrogen promotes rapid, leafy green growth and builds plant materials, 
phosphorus helps the plant produce seeds and form roots, and potassium 
improves fruit quality and disease resistance. Therefore, most fertilizers used by 
farmers, ranchers, and gardeners today contain some amount of each of these 
elements. In fact, fertilizers can be distinguished by the ratio of NPK labeled on 
the bag. In addition to N, P, and K, there are a variety of other minerals that are 
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added for deficient soils in certain areas. The essential micronutrients are: 
Chlorine, Iron, Boron, Manganese, Zinc, Copper, Molybdenum, and Nickel, most 
of which are important in enzyme activities. Note that Iron is considered an 
important micronutrient, which in some areas may be lacking in the soil in a 
readily available form for plant use. Therefore, some fertilizers contain Iron in a 
form that plants can use but it is usually found only in parts per million to 
milligram concentrations, not as a percentage, like Milorganite®. 
There are two types of fertilizer: man-made and organic. Man-made 
fertilizers are manufactured in water-soluble forms whereas organic fertilizers are 
of biological origin and contain organic material that is in the process of 
decomposing. Processed organic fertilizers have a biological origin but have 
already undergone decomposition and contain nutrients in a readily available 
form for plants. This processing of organic fertilizer can result in innumerable 
forms of iron salts and chelates. And, the form of the iron compounds within 
processed organic fertilizers may differ greatly between processing methods. 
The iron bioavailability therefore needed to be examined in order to determine 
the possibility of iron toxicosis if the product is accidentally ingested. 
The main reason for conducting a dosing study is to investigate the 
potential adverse effects offertilizer ingestion by humans (especially children) or 
copraphagic animals (especially dogs). Dogs, being copraphagic in nature, are 
attracted to fertilizers that are made of fecal material. The reason for conducting 
a dosing study in rats is because the bioavailability of the contents of the fertilizer 
are most readily studied in an animal model. Rats are good animal models for 
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bioavailability studies concerning dogs and humans because of their similar 
monogastric digestive system, metabolism, and methods of iron processing. 
Conducting a single study in this manner is also much simpler than conducting 
many studies in an attempt to determine the individual forms of the irons and 
their individual effects. 
EXPERIMENTAL DESIGN 
First, 36 rats were allowed to acclimate for one week before dosing and 
were weighed once at the beginning of the week and then again 24 hours before 
dosing. After acclimation, the rats were randomly assigned to one of six 
treatment groups to be dosed with 0, 100, 500, 1000, 1500, or 2000 milligrams of 
fertilizer per kilogram of body weight. The Milorganite® fertilizer product utilized 
was 6.8% iron. The rats were gavaged by dosing needle with ground fertilizer 
suspended in peanut oil (suspensions in water proved to be unsuccessful). 
During the acclimation and after dosing, the rats were given rat chow and water 
ad libitum and were monitored for one week for normal behavior, activity, eating, 
drinking, respiration, and feces production. After one week, the rats were 
euthanized in a CO2 chamber. The chest cavity was opened and blood collected 
via cardiac puncture. Finally, tissues were collected for mineral analyses and 
pathologic evaluation. Mineral analyses were performed by Inductively Coupled 
Plasma/Mass Spectroscopy on the livers, kidneys, and small intestines (that had 
been washed in sterile water to remove the contents). Pathologic evaluations 
were performed on all of the major organ systems. 
RESULTS 
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Clinically, we observed two animals with dosing complications. On day 1, 
these animals were removed from the study due to esophageal damaged 
sustained at dosing. All other rats appeared healthy and normal for the week 
following dosing. There were no differences in weight gain between the six 
treatment groups that were observed. 
Histologically there were no lesions in any tissues identified in any of the 
treatment groups. 
The serum iron and iron binding capacity were identical among all 
treatment groups as well. These two tests were performed to determine if iron 
was in excess in the body. If the serum iron is greater than the iron biding 
capacity (which is typically between 40 and 60% saturated) then there is free iron 
in circulation that can lead to iron toxicity. Our findings, however, maintained the 
correct ratios for all the treatment groups (serum iron was less than the iron 
biding capacity). A full serum chemistry panel including Total Protein, Albumen, 
Creatinine Phosphokinase, Alkaline Phosphatase, Sodium, Potassium, Calcium, 
Lactate Dehydrogenase, Creatinine, Blood Urea Nitrogen, Cholesterol, Total 
Bilirubin, and Aspartate Aminotransferase was analyzed and had no 
abnormalities or differences among the treatment groups. 
Minimal differences in tissue mineral contents were identified. The 
mineral analyses of the kidney showed an increase in Nickel and Vanadium as 
dose increased. The small intestine analyses did not show any differences 
between the treatment groups for any minerals. Finally, the liver showed an 
unexplained statistical difference among treatments for Chromium, Nickel, and 
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Phosphorus. The differences are, however, illogical because the low and high 
dose groups showed similarities that were statistically different from the middle 
dose groups. Please see the attached tables for results of each tissue analyzed 
(Table 1-3). Iron, the primary mineral of interest had no differences among 
treatments for any of the tissues analyzed. 
SUMMARY 
To summarize, the high iron content in aerobically processed fertilizer 
proved to be not bioavailable as evidenced by the lack of increase in serum iron, 
iron binding capacity, and tissue iron content. Nickel and Vanadium, however, 
were bioavailable as observed by increasing concentrations in the kidney as 
dose increased. However, it must be remembered that this study was only a 
one-dose study and a long-term accumulation study is needed to investigate the 
severity and consequences of bioaccumulation of these minerals. Overall, this 
study noted no adverse effects due to the Milorganite® fertilizer product 
containing 6.8% iron. 
In conclusion, Milorganite® fertilizer does not pose a health risk from the 
high iron content after acute ingestion. In addition, other minerals in Milorganite® 
did not result in adverse effects even though there seemed to be a dose 
response increase in Nickel and Vanadium in the kidney. Also, a study with 
multiple exposures is needed to assess the bioaccumulation of these minerals 
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TABLE 1 Milorganite Single Dose Study Rat Kidney Stats 
Sample group Control 100 mg/kg 500 mg/kg 1000 mg/kg 1500 mg/kg 2000 mg/kg 
Element Mean Std. Dev Mean Std. Dev Mean Std. Dev Mean Std. Dev Mean Std. Dev Mean Std. Dev 
Ag 0.000 0.0000 0.000 0.0002 0.000 0.0004 0.000 0.0007 0.000 0.0000 0.000 0.0000 
Al 0.067 0.0389 0.057 0.0340 0.094 0.0874 0.103 0.0248 0.071 0.0175 0.086 0.0558 
As 0.344 0.0981 0.273 0.0177 0.320 0.0955 0.542 0.2735 0.345 0.0690 0.427 0.1045 
B 0.232 0.0376 0.270 0.0718 0.261 0.0667 0.174 0.1193 0.247 0.0506 0.287 0.0779 
Ba 0.006 0.0037 0.005 0.0024 0.006 0.0049 0.005 0.0033 0.003 0.0005 0.004 0.0010 
Be 0.000 0.0002 0.000 0.0000 0.000 0.0002 0.000 0.0003 0.000 0.0000 0.000 0.0002 
Ca 84.257 5.9659 89.409 17.3893 82.736 4.8375 85.280 3.1146 77.224 4.4053 78.569 5.5603 
Cd 0.033 0.0443 0.016 0.0041 0.012 0.0024 0.014 0.0037 0.014 0.0023 0.016 0.0030 
Co 0.152 0.0247 0.163 0.0140 0.170 0.0188 0.176 0.0193 0.159 0.0144 0.148 0.0100 
Cr 0.174 0.0150 0.194 0.0151 0.186 0.0159 0.188 0.0065 0.179 0.0122 0.198 0.0255 
Cu 6.995 1.5395 7.203 1.3919 7.458 1.6908 5.895 1.0079 6.139 0.8840 7.770 1.1850 
Fe 50.921 9.0869 46.071 2.5490 50.186 10.1711 67.711 20.1378 52.789 4.4447 61.243 11.7491 
K 2502.381 84.1871 2557.431 119.8337 2490.638 64.0854 2637.595 48.6252 2544.644 46.9198 2594.804 106.3562 
Li 0.011 0.0033 0.010 0.0040 0.011 0.0028 0.010 0.0050 0.011 0.0029 0.012 0.0040 
Mg 186.902 5.8493 190.792 8.9661 183.776 5.1545 193.613 7.0656 183.862 8.6350 190.789 5.8849 
Mn 0.819 0.0445 0.825 0.0611 0.802 0.0579 0.851 0.0742 0.789 0.0581 0.820 0.0528 
Mo 0.270 0.0240 0.274 0.0156 0.276 0.0102 0.279 0.0208 0.272 0.0329 0.288 0.0227 
Na 1384.445 47.6541 1441.137 91.7632 1407.876 106.1304 1493.085 65.6371 1394.329 110.2174 1440.818 80.8921 
Ni 0.004 0.0049 0.006 0.0024 0.005 0.0044 0.020 0.0150 0.008 0.0017 0.010 0.0057 
p 2795.539 145.4647 2898.208 129.1308 2821.590 109.3744 3006.448 115.8223 2860.356 159.8496 2962.590 139.4154 
Pb 0.005 0.0040 0.005 0.0017 0.004 0.0011 0.005 0.0026 0.003 0.0006 0.009 0.0064 
Sb 0.001 0.0014 0.001 0.0013 0.001 0.0012 0.001 0.0016 0.001 0.0016 0.001 0.0016 
Se 1.339 0.1399 1.271 0.1100 1.276 0.1039 1.466 0.1189 1.351 0.0724 1.381 0.0654 
Si 16.466 1.6849 16.781 1.1494 16.946 1.2079 18.091 1.1999 17.045 1.3634 17.936 1.8509 
Sn 0.003 0.0010 0.004 0.0017 0.003 0.0003 0.005 0.0029 0.004 0.0012 0.004 0.0012 
Sr 0.026 0.0041 0.032 0.0082 0.027 0.0048 0.030 0.0081 0.025 0.0017 0.025 0.0038 
Tl 0.017 0.0016 0.016 0.0013 0.014 0.0021 0.015 0.0023 0.015 0.0016 0.016 0.0016 
V 0.024 0.0028 0.028 0.0040 0.032 0.0033 0.054 0.0233 0.041 0.0034 0.040 0.0033 
Zn 20.480 1.2479 20.749 0.9845 20.174 0.6556 21.086 1.2428 19.815 0.8000 21.284 1.0326 
Page 1 
TABLE 2 Milorganite Single Dose Study Rat Liver Stats 
Sample group Control 100 mg/kg 500 mg/kg 1000 mg/kg 1500 mg/kg 2000 mg/kg 
Element Mean Std. Dev Mean Std. Dev Mean Std. Dev Mean Std. Dev Mean Std. Dev Mean Std. Dev 
Ag 0.001 0.0026 0.000 0.0005 0.000 0.0007 0.002 0.0027 0.000 0.0000 0.000 0.0005 
Al 0.098 0.0065 0.140 0.0597 0.143 0.0442 0.157 0.0238 0.141 0.0394 0.139 0.0373 
As 0.368 0.0279 0.334 0.0637 0.353 0.0865 0.449 0.2424 0.381 0.0762 0.332 0.0149 
B 0.147 0.0223 0.145 0.0332 0.157 0.0289 0.124 0.0778 0.157 0.0322 0.172 0.0383 
Ba 0.002 0.0007 0.005 0.0043 0.003 0.0010 0.003 0.0016 0.003 0.0011 0.004 0.0018 
Be 0.000 0.0000 0.000 0.0000 0.000 0.0002 0.000 0.0000 0.000 0.0003 0.000 0.0003 
Ca 56.112 3.3815 59.896 9.3481 57.822 3.1103 59.776 4.4725 65.540 9.4624 56.982 6.8562 
Cd 0.011 0.0089 0.007 0.0009 0.006 0.0016 0.007 0.0010 0.007 0.0008 0.007 0.0010 
Co 0.037 0.0049 0.039 0.0055 0.043 0.0140 0.042 0.0078 0.034 0.0086 0.035 0.0059 
Cr 0.176 0.0122 0.172 0.0151 0.160 0.0116 0.145 0.0108 0.181 0.0109 0.171 0.0190 
Cu 4.470 0.1640 4.425 0.4408 4.184 0.1406 4.778 0.6017 4.438 0.1952 4.371 0.3456 
Fe 100.147 5.4267 102.515 5.7293 112.106 20.7134 112.104 28.7545 111.710 7.8615 92.228 13.7745 
K 3507.296 114.8295 3463.598 68.8209 3473.393 118.3987 3619.955 129.3473 3488.297 92.7870 3461.037 165.4806 
Li 0.006 0.0035 0.007 0.0034 0.007 0.0042 0.006 0.0041 0.006 0.0070 0.009 0.0069 
Mg 222.186 3.5024 221.754 9.5358 219.682 6.4670 236.597 12.9617 222.572 4.2614 222.907 8.0088 
Mn 2.673 0.1408 2.798 0.2367 2.630 0.0716 2.596 0.3558 2.880 0.1596 2.776 0.2139 
Mo 0.711 0.0355 0.707 0.0246 0.685 0.0519 0.734 0.0957 0.731 0.0335 0.753 0.0800 
Na 612.083 31.4696 595.004 64.6896 633.646 33.6183 663.472 100.5783 651.516 28.8900 641.996 62.7110 
Ni 0.002 0.0008 0.005 0.0031 0.001 0.0008 0.004 0.0020 0.001 0.0013 0.002 0.0019 
p 3898.115 60.4746 3744.661 122.4197 3633.079 143.1106 3863.544 249.8933 4005.239 93.1761 3654.985 205.9796 
Pb 0.001 0.0006 0.002 0.0025 0.002 0.0019 0.003 0.0017 0.002 0.0029 0.001 0.0007 
Sb 0.001 0.0024 0.001 0.0026 0.002 0.0026 0.002 0.0027 0.002 0.0029 0.002 0.0030 
Se 1.094 0.0676 1.052 0.0485 1.071 0.0489 1. 100 0.0998 1.059 0.0492 1.043 0.0849 
Si 30.416 1.4936 30.997 2.3755 26.097 4.2300 24.888 1.4334 28.462 2.2619 28.013 4.6468 
Sn 0.001 0.0017 0.002 0.0016 0.002 0.0010 0.004 0.0030 0.002 0.0024 0.002 0.0018 
Sr 0.011 0.0015 0.015 0.0070 0.014 0.0026 0.017 0.0047 0.017 0.0046 0.014 0.0026 
Tl 0.002 0.0002 0.002 0.0003 0.002 0.0002 0.002 0.0003 0.002 0.0003 0.002 0.0003 
V 0.011 0.0008 0.012 0.0017 0.011 0.0013 0.021 0.0157 0.015 0.0015 0.014 0.0020 
Zn 29.691 0.7828 29.0954 1.5788 28.218 1.0013 34.457 6.8559 31.202 1.5027 28.529 0.8762 
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TABLE 3 Milorganite Single Dose Study Rat Small Intestines Stats 
Sample group Control 100 mg/kg 500 mg/kg 1000 mg/kg 1500 mg/kg 2000 mg/kg 
Element Mean Std. Dev Mean Std. Dev Mean Std. Dev Mean Std. Dev Mean Std. Dev Mean Std. Dev 
Ag 0.000 0.0002 0.000 0.0000 0.000 0.0003 0.000 0.0012 0.000 0.0000 0.000 0.0006 
Al 0.395 0.1647 0.485 0.3203 0.555 0.3309 0.448 0.2559 0.415 0.2536 0.978 1.1552 
As 0.060 0.0118 0.052 0.0063 0.072 0.0127 0.060 0.0161 0.065 0.0164 0.080 0.0309 
B 0.153 0.0281 0.156 0.0321 0.162 0.0321 0.145 0.1058 0.163 0.0591 0.259 0.1307 
Ba 0.038 0.0163 0.046 0.0374 0.053 0.0348 0.022 0.0286 0.032 0.0289 0.084 0.0956 
Be 0.000 0.0002 0.000 0.0000 0.000 0.0000 0.000 0.0000 0.000 0.0000 0.000 0.0002 
Ca 133.900 19.2475 157.788 48.3198 160.167 49.6909 142.992 53.3900 153.199 32.9687 187.261 81.3671 
Cd 0.033 0.0642 0.004 0.0047 0.003 0.0008 0.015 0.0297 0.003 0.0010 0.004 0.0016 
Co 0.015 0.0041 0.014 0.0024 0.018 0.0059 0.013 0.0061 0.017 0.0090 0.015 0.0041 
Cr 0.139 0.0216 0.147 0.0315 0.181 0.0606 0.171 0.0550 0.203 0.0725 0.204 0.0917 
Cu 1.536 0.1491 1.366 0.0945 1.507 0.2574 1.484 0.2784 1.565 0.2200 1.543 0.2920 
Fe 12.497 2.9030 12.315 0.5494 14.165 2.6970 12.308 2.5983 13.276 2.1822 13.317 3.3582 
K 2555.967 267.4238 2523.268 402.0085 2599.000 473.4581 2626.284 690.8316 2719.641 183.0196 2425.638 279.0190 
Li 0.011 0.0050 0.010 0.0043 0.009 0.0032 0.011 0.0094 0.012 0.0062 0.018 0.0110 
Mg 179.133 18.7092 170.535 10.8935 191.589 30.1184 174.447 49.9318 189.058 24.6540 180.072 28.9378 
Mn 0.954 0.2541 1.010 0.1280 1.264 0.5241 1.097 0.3270 1.088 0.3323 1.431 0.8394 
Mo 0.153 0.0239 0.132 0.0136 0.134 0.0260 0.127 0.0419 0.135 0.0230 0.147 0.0454 
Na 1650.192 194.4901 1574.501 157.2891 1668.410 180.1173 1218.572 587.0473 1495.523 166.6660 1668.667 289.8123 
Ni 0.022 0.0130 0.019 0.0109 0.037 0.0264 0.027 0.0183 0.035 0.0193 0.032 0.0087 
p 2400.448 397.3695 2252.434 210.8535 2390.429 339.4894 2357.152 520.5701 2611.433 172.5872 2264.939 371.1685 
Pb 0.002 0.0007 0.004 0.0029 0.004 0.0041 0.002 0.0012 0.002 0.0015 0.004 0.0025 
Sb 0.001 0.0025 0.001 0.0018 0.001 0.0022 0.002 0.0035 0.002 0.0027 0.005 0.0052 
Se 0.366 0.0304 0.344 0.0304 0.348 0.0598 0.312 0.0970 0.330 0.0201 0.320 0.0396 
Si 17.712 1.1928 16.744 1.7986 22.492 4.3355 18.424 3.2271 21.967 1.7482 24.892 6.4100 
Sn 0.003 0.0035 0.001 0.0011 0.002 0.0009 0.002 0.0015 0.003 0.0024 0.003 0.0018 
Sr 0.070 0.0306 0.097 0.0582 0.092 0.0545 0.068 0.0503 0.069 0.0315 0.143 0.1125 
Tl 0.002 0.0004 0.002 0.0002 0.002 0.0005 0.003 0.0010 0.003 0.0005 0.003 0.0012 
V 0.018 0.0051 0.021 0.0061 0.027 0.0139 0.065 0.0465 0.034 0.0129 0.032 0.0166 
Zn 20.408 1.9403 22.599 4.3103 26.605 4.7994 24.965 5.8584 27.100 4.3224 22.990 3.9378 
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